Wells Fargo’s Context Therapeutics CNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-116
| Closed | -$160 | – | 6585 |
|
|
2024
Q1 | $160 | Buy |
116
+2
| +2% | +$3 | ﹤0.01% | 6154 |
|
|
2023
Q4 | $129 | Buy |
114
+6
| +6% | +$7 | ﹤0.01% | 6262 |
|
|
2023
Q3 | $163 | Buy |
108
+1
| +0.9% | +$2 | ﹤0.01% | 6258 |
|
|
2023
Q2 | $171 | Buy |
107
+4
| +4% | +$6 | ﹤0.01% | 6435 |
|
|
2023
Q1 | $58 | Buy |
103
+2
| +2% | +$1 | ﹤0.01% | 6746 |
|
|
2022
Q4 | $66 | Buy |
101
+2
| +2% | +$1 | ﹤0.01% | 6588 |
|
|
2022
Q3 | $0 | Buy |
99
+30
| +43% | – | ﹤0.01% | 6398 |
|
|
2022
Q2 | $0 | Buy |
69
+5
| +8% | – | ﹤0.01% | 6562 |
|
|
2022
Q1 | $0 | Buy |
64
+31
| +94% | – | ﹤0.01% | 6714 |
|
|
2021
Q4 | $0 | Buy |
+33
| New | – | ﹤0.01% | 6697 |
|